Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Guelph

$27,000.00

The role of mast cell activation in modulating macrophage phenotype during bacterial meningitis

FY 2025-26

Summary
Pneumococcal meningitis is a deadly bacterial infection of the linings that surround the brain, called the meninges. This disease is highly fatal despite antibiotic treatment, and those who survive often experience chronic symptoms. The meninges are dense in a variety of immune cells, including two cell types called mast cells (MCs) and macrophages. MCs are often the first responder to infection, detecting bacteria as they invade the body, and then they alert the rest of the immune system to the threat. One of the components of the immune system MCs interact with are macrophages which are antibacterial cells. While we known that MCs can enhance the ability of macrophages to kill bacteria (albeit the evidence is weak), we do not know how MCs activated by bacterial molecules affect macrophage function in the context of pneumococcal infection. This project aims to understand the way MCs affect the antibacterial function of macrophages in the meninges with the goal of developing future treatments for patients with pneumococcal meningitis. This will be investigated in 3 steps. Initially, MCs activated by bacterial molecules will be incubated with macrophages to determine the cellular interactions in an isolated system. Next, macrophages will be activated by MCs and the ability of macrophages to kill bacteria will be measured. Finally, to confirm findings in an animal model, mice will be injected into the meninges with Streptococcus pneumoniae, the causative agent of pneumococcal meningitis, and mouse meningeal tissue will be isolated and stained for common markers of macrophage function. This research will help inform important cellular interactions in the early stages of pneumococcal meningitis, helping to develop immune system-based treatments in the future.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
572913
Name
Pozniak Austin
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The role of mast cell activation in modulating macrophage phenotype during bacterial meningitis
Programtype2
Studentship Programs
Orgnameinp2
University of Guelph
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Host-Pathogen Interactions; Macrophages; Mast Cells; Meningitis; Streptococcus Pneumoniae
Abstract
Pneumococcal meningitis is a deadly bacterial infection of the linings that surround the brain, called the meninges. This disease is highly fatal despite antibiotic treatment, and those who survive often experience chronic symptoms. The meninges are dense in a variety of immune cells, including two cell types called mast cells (MCs) and macrophages. MCs are often the first responder to infection, detecting bacteria as they invade the body, and then they alert the rest of the immune system to the threat. One of the components of the immune system MCs interact with are macrophages which are antibacterial cells. While we known that MCs can enhance the ability of macrophages to kill bacteria (albeit the evidence is weak), we do not know how MCs activated by bacterial molecules affect macrophage function in the context of pneumococcal infection. This project aims to understand the way MCs affect the antibacterial function of macrophages in the meninges with the goal of developing future treatments for patients with pneumococcal meningitis. This will be investigated in 3 steps. Initially, MCs activated by bacterial molecules will be incubated with macrophages to determine the cellular interactions in an isolated system. Next, macrophages will be activated by MCs and the ability of macrophages to kill bacteria will be measured. Finally, to confirm findings in an animal model, mice will be injected into the meninges with Streptococcus pneumoniae, the causative agent of pneumococcal meningitis, and mouse meningeal tissue will be isolated and stained for common markers of macrophage function. This research will help inform important cellular interactions in the early stages of pneumococcal meningitis, helping to develop immune system-based treatments in the future.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pozniak, Austin
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~